APLLTDNSEAlembic Pharmaceuticals Limited· PharmaceuticalsMediumNegative
Announced Mon, 4 May · 19:31 IST

Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Senior Management Personnel

Management Changes View source PDF

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹766.50
prior close
₹767.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3+0.5-0.0+0.6+2.4+0.8+2.7+3.1-0.2+2.4-1.0-3.1+8.9
Up moveDown movePending
AI summary

Alembic Pharmaceuticals has announced the resignation of Mr. Goldee Pardesi from his position as Associate Vice President - Sales & Marketing, effective 4th May 2026 (close of business hours). The resignation was submitted via email on 3rd February 2026, with Mr. Pardesi citing pursuit of new opportunities aligned with his professional and personal goals. The company has filed this intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is a senior management-level departure in the sales and marketing function and does not involve board-level or key managerial personnel as defined under the Companies Act.

Likely market impact

The departure of the AVP Sales & Marketing is unlikely to have any material impact on Alembic Pharmaceuticals' stock price or operations, as this is a mid-senior level management change. The company has sufficient time to identify a replacement or restructure the sales and marketing function.